B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Linsitinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Linsitinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cep
10 shared targets
fostamatinib
6 shared targets
lenvatinib
7 shared targets
cabozantinib
7 shared targets
orantinib
7 shared targets
tak
3 shared targets
Vemurafenib
7 shared targets · score 43.2
barasertib
5 shared targets
tivozanib
7 shared targets
mirdametinib
3 shared targets
Loading evidence profile...

This evidence profile for Linsitinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.